Adaptive Biotechnologies (ADPT) Competitors $4.42 -0.06 (-1.34%) (As of 11/20/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends ADPT vs. KOD, FLDM, NVAX, SRRK, IOVA, TWST, CGON, APGE, BEAM, and RXRXShould you be buying Adaptive Biotechnologies stock or one of its competitors? The main competitors of Adaptive Biotechnologies include Kodiak Sciences (KOD), Fluidigm (FLDM), Novavax (NVAX), Scholar Rock (SRRK), Iovance Biotherapeutics (IOVA), Twist Bioscience (TWST), CG Oncology (CGON), Apogee Therapeutics (APGE), Beam Therapeutics (BEAM), and Recursion Pharmaceuticals (RXRX). These companies are all part of the "medical" sector. Adaptive Biotechnologies vs. Kodiak Sciences Fluidigm Novavax Scholar Rock Iovance Biotherapeutics Twist Bioscience CG Oncology Apogee Therapeutics Beam Therapeutics Recursion Pharmaceuticals Kodiak Sciences (NASDAQ:KOD) and Adaptive Biotechnologies (NASDAQ:ADPT) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their valuation, analyst recommendations, earnings, media sentiment, dividends, profitability, risk, institutional ownership and community ranking. Do institutionals and insiders believe in KOD or ADPT? 89.1% of Kodiak Sciences shares are owned by institutional investors. Comparatively, 99.2% of Adaptive Biotechnologies shares are owned by institutional investors. 45.3% of Kodiak Sciences shares are owned by insiders. Comparatively, 6.2% of Adaptive Biotechnologies shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term. Which has more volatility & risk, KOD or ADPT? Kodiak Sciences has a beta of 2.26, suggesting that its share price is 126% more volatile than the S&P 500. Comparatively, Adaptive Biotechnologies has a beta of 1.45, suggesting that its share price is 45% more volatile than the S&P 500. Does the MarketBeat Community believe in KOD or ADPT? Adaptive Biotechnologies received 76 more outperform votes than Kodiak Sciences when rated by MarketBeat users. Likewise, 57.32% of users gave Adaptive Biotechnologies an outperform vote while only 26.47% of users gave Kodiak Sciences an outperform vote. CompanyUnderperformOutperformKodiak SciencesOutperform Votes1826.47% Underperform Votes5073.53% Adaptive BiotechnologiesOutperform Votes9457.32% Underperform Votes7042.68% Does the media refer more to KOD or ADPT? In the previous week, Adaptive Biotechnologies had 2 more articles in the media than Kodiak Sciences. MarketBeat recorded 13 mentions for Adaptive Biotechnologies and 11 mentions for Kodiak Sciences. Adaptive Biotechnologies' average media sentiment score of 0.81 beat Kodiak Sciences' score of 0.27 indicating that Adaptive Biotechnologies is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Kodiak Sciences 2 Very Positive mention(s) 1 Positive mention(s) 6 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Adaptive Biotechnologies 5 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Is KOD or ADPT more profitable? Kodiak Sciences has a net margin of 0.00% compared to Adaptive Biotechnologies' net margin of -110.13%. Adaptive Biotechnologies' return on equity of -62.06% beat Kodiak Sciences' return on equity.Company Net Margins Return on Equity Return on Assets Kodiak SciencesN/A -84.52% -45.40% Adaptive Biotechnologies -110.13%-62.06%-26.82% Which has better earnings & valuation, KOD or ADPT? Adaptive Biotechnologies has higher revenue and earnings than Kodiak Sciences. Adaptive Biotechnologies is trading at a lower price-to-earnings ratio than Kodiak Sciences, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioKodiak SciencesN/AN/A-$260.49M-$3.65-1.59Adaptive Biotechnologies$170.28M3.83-$225.25M-$1.34-3.30 Do analysts rate KOD or ADPT? Kodiak Sciences presently has a consensus price target of $3.50, indicating a potential downside of 39.55%. Adaptive Biotechnologies has a consensus price target of $6.50, indicating a potential upside of 47.06%. Given Adaptive Biotechnologies' stronger consensus rating and higher possible upside, analysts clearly believe Adaptive Biotechnologies is more favorable than Kodiak Sciences.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Kodiak Sciences 2 Sell rating(s) 2 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50Adaptive Biotechnologies 0 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.75 SummaryAdaptive Biotechnologies beats Kodiak Sciences on 13 of the 17 factors compared between the two stocks. Ad Brownstone ResearchMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrough so advanced, it’s going to make ChatGPT look like VHS. But what’s even more unbelievable? I believe it’ll make Nvidia’s meteoric rise look like a backyard bottle rocket.Click here and I’ll tell you everything you need to know. Get Adaptive Biotechnologies News Delivered to You Automatically Sign up to receive the latest news and ratings for ADPT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ADPT vs. The Competition Export to ExcelMetricAdaptive BiotechnologiesBiological Products IndustryMedical SectorNASDAQ ExchangeMarket Cap$652.30M$2.93B$5.01B$8.81BDividend YieldN/A1.89%5.16%4.06%P/E Ratio-3.3045.25134.3717.77Price / Sales3.83360.241,158.6875.18Price / CashN/A160.0933.5332.53Price / Book2.083.734.674.68Net Income-$225.25M-$41.63M$119.07M$226.08M7 Day Performance-20.79%-4.73%-1.83%-1.04%1 Month Performance-2.86%-6.53%-3.62%1.04%1 Year Performance4.74%25.63%31.63%26.28% Adaptive Biotechnologies Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ADPTAdaptive Biotechnologies4.3913 of 5 stars$4.42-1.3%$6.50+47.1%-0.5%$652.30M$170.28M-3.30709Short Interest ↓Analyst RevisionKODKodiak Sciences2.9773 of 5 stars$5.79+2.7%$3.50-39.6%+138.3%$304.69MN/A-1.5990FLDMFluidigmN/AN/AN/AN/A$283.76M$130.58M-4.76615NVAXNovavax3.672 of 5 stars$8.06+0.8%$17.83+121.3%+41.4%$1.28B$983.71M0.001,543Analyst RevisionSRRKScholar Rock4.1709 of 5 stars$27.86flat$34.00+22.0%+137.1%$2.61B$33.19M0.00140IOVAIovance Biotherapeutics4.0443 of 5 stars$8.14-0.6%$22.33+174.4%+48.3%$2.48B$1.19M-5.46500Options VolumeTWSTTwist Bioscience4.1382 of 5 stars$41.11-0.5%$51.78+25.9%+66.2%$2.45B$312.97M0.00990Analyst ForecastAnalyst RevisionCGONCG Oncology3.1626 of 5 stars$32.24-1.7%$63.88+98.1%N/A$2.18B$684,000.000.0061Short Interest ↓Analyst RevisionAPGEApogee Therapeutics2.241 of 5 stars$45.04-3.2%$78.50+74.3%+149.9%$2.03BN/A-18.6191BEAMBeam Therapeutics2.9185 of 5 stars$24.49-3.2%$44.91+83.4%-20.4%$2.03B$377.71M-13.91461RXRXRecursion Pharmaceuticals1.9932 of 5 stars$6.04-3.7%$9.25+53.1%-12.0%$1.80B$44.58M0.00400Analyst ForecastOptions VolumeHigh Trading Volume Related Companies and Tools Related Companies Kodiak Sciences Competitors Fluidigm Competitors Novavax Competitors Scholar Rock Competitors Iovance Biotherapeutics Competitors Twist Bioscience Competitors CG Oncology Competitors Apogee Therapeutics Competitors Beam Therapeutics Competitors Recursion Pharmaceuticals Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:ADPT) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Adaptive Biotechnologies Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Adaptive Biotechnologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ADPT Stock Alerts